Article
Targeting CXCR1 and CXCR2 to overcome radiotherapy resistance in PTEN-deficient prostate carcinoma
2020-03-16
Abstract excerpt
<h4> ABSTRACT </h4> Functional impairment of the tumour-suppressor PTEN is common in primary-prostate cancer and has been linked to relapse post-radiotherapy (RT). Pre-clinical modelling supports elevated CXC-chemokine signaling as a critical mediator of PTEN -depleted disease progression and therapeutic resistance. We assessed the correlation of PTEN -deficiency with CXC-chemokine signaling and its associati...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5eff399d-1fd1-5001-ac0b-7d2d7df9c562
- DOI
- 10.1101/2020.03.16.993394
